This book is intended to show the great achievements and valuable experience of Chinese public health practices and epidemiological theories and methods. It is conducive to expanding medical workers’ practical ability of disease prevention and control, and to bridging the gap between clinical medicine and public health. In part 1, it introduces the progress in epidemiology of 10 infectious diseases. In part 2, it covers 11 non-communicable diseases. The research method and prediction modelling and public health ethics are discussed in the 11 chapters of part 3. The contributors include epidemiologists and public health experts, as well as more clinicians, mathematicians, sociologists, philosophers (ethicists), bioinformatics and so on. Among them, there are not only professors from universities, but also researchers from scientific research institutes, and experts in the front line of disease prevention and control.

This edited volume presents a detailed portrait of couples living with mixed HIV status, where one partner is HIV-positive and the other negative. Readers will come to understand the various and complex ways in which these mixed-status, or serodiscordant couples build a life together within the shadow of HIV-related stigma. Spanning the globe, coverage explores serodiscordance as a negotiated practice and process, inseparable from the social context in which it is situated. The book shows how couples draw on diverse and sometimes contradictory cultural discourses of medicine, romance, and “normality” to make sense of and manage their mixed HIV status and any perceived risks, not uncommonly in ways that depart from prevailing HIV prevention messages. Throughout, compelling personal stories accompany the empirical research, sharing the firsthand experiences of men and women in serodiscordant relationships. Bringing together research from diverse disciplines and geographical regions, this book contributes important insights for future HIV health promotion as well as offers new knowledge to scholarship on the cultural intersections of illness and intimacy. It will appeal to a broad audience working across the fields of HIV, health, gender, sexuality, development, and human rights.

A need for a book on immunology which primarily focuses on the needs of medical and clinical research students was recognized. This book, "Immunosuppression - Role in Health and Diseases" is relatively short and contains topics relevant to the understanding of human immune system and its role in health and diseases. Immunosuppression involves an act that reduces the activation or efficacy of the immune system. Therapeutic immunosuppression has applications in clinical medicine, ranging from prevention and treatment of organ/bone marrow transplant rejection, management of autoimmune and inflammatory disorders. It brings important developments both in the field of molecular mechanisms involved and active therapeutic approaches employed for immunosuppression in various human disease conditions. There was a need to bring this information together in a single volume, as much of the recent developments are dispersed throughout biomedical literature, largely in specialized journals. This book will serve well the practicing physicians, surgeons and biomedical scientists as it provides an insight into various approaches to immunosuppression and reviews current developments in each area.

Diversity, Distribution, and Current Status is the first volume in a three-volume series dedicated to the analysis of this important group of plant pathogens across Asia with a particular focus on geographic distribution. This book offers updated data on the most prevalent phytoplasma diseases specific to each region. Phytoplasmas are emerging plant pathogens all around the world, causing significant economic losses to crops, as well as affecting international trade. The chapters in Volume 1 look closely at different countries and regions across Asia, providing data on country-wide distribution, phytoplasma groups, insect vectors and transmission. The Phytoplama Diseases in Asian Countries series will be an essential read for university students, researchers and agriculturalists interested in Plant Pathology. Volume 1 will be of particular interest to those needing the latest data on the distribution and transmission rates specific to the various regions of Asia. - Reviews the geographical distribution of different phytoplasma diseases across Asia - Organized by country, providing an in-depth analysis of the phytoplasma prevalent in different regions - Provides a wealth of data associated with each phytoplasma disease - Highlights the insect vectors transmitting the bacteria

October is the Liver Cancer Awareness Month and at Frontiers in Oncology we want to highlight the recent discoveries in the field and raise awareness of the importance of early diagnosis, multidisciplinary management, and technological innovation support. Primary liver cancer represents a significant global health challenge, with its incidence steadily rising and posing substantial morbidity and mortality rates. This research topic in Frontiers in Oncology focuses on the latest advancements in the investigation and treatment of primary liver cancer, addressing hepatocellular carcinoma (HCC) and cholangiocarcinoma to provide insights into cutting-edge approaches to shaping the field and improving patient outcomes

National Institute of Parasitic Diseases, China: 70 Years and Beyond, Volume 110 covers the major achievements gained in the research and control of parasitic diseases in China, e.g. schistosomiasis, malaria, lymphatic filariasis, echinococcosis, visceral leishmaniasis, soil-transmitted helminthiasis, foodborne clonorchiasis, angiostrongyliasis, taeniasis and cysticercosis, etc. The book introduces approaches that can be developed with big data analytic tools, how to use surveillance-response systems at national and regional levels, and tactics to promote the national parasitic resources center to support various research and control activities. Finally, a chapter on the roadmap for parasitic diseases control in China from 2020 to 2030 is presented. - Informs and updates on the controlled progress of parasitic diseases in China, with a focus on strategies, combating measures, surveillance-response systems, and multi-sectoral cooperation - Introduces advances in research achievements in the development of diagnostics, drugs, insecticides and surveillance tools - Features reviews of more traditional parasitic diseases that help to shape current thinking and applications of modern tools in research and control of diseases

Each issue lists papers published during the preceding year.